Arbutus Biopharma Corporation Common Stock. Replay the stock market charts of ABUS day by day back to 2003. Open long and short positions without spending any money. Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
